TG Therapeutics Inc (TGTX)
32.16
-0.10
(-0.31%)
USD |
NASDAQ |
Dec 24, 16:00
TG Therapeutics Profit Margin (Quarterly): 4.63% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Zoetis Inc | 28.56% |
| Rhythm Pharmaceuticals Inc | -131.2% |
| Warby Parker Inc | -2.12% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.40% |
| Return on Assets | -3.55% |
| Return on Invested Capital | -4.78% |
| Gross Profit Margin (Quarterly) | 88.86% |
| Operating Margin (Quarterly) | 14.82% |
| Return on Net Operating Assets | -9.88% |